As the IHC of epilepsy cohorts showed a consistent expression of KDM1A in astrocytes, in vitro validation of the role of KDM1A was assessed using PMA/Ionomycin stimulated fetal astrocytes (treatment at 3 h and 6 h). This evidence concerns the gene KDM1A and epilepsy.